Completed NA INTERVENTIONAL 2-arm NCT03758118

Citicoline in Non-Arteritic Ischemic Optic Neuropathy

Neuroprotection and Neuroenhancement in a Model of Optic Nerve Neurodegeneration (Non Arteritic Ischemic Optic Neuropathy): Study of Morpho-functional Changes Related to Treatment With Citicoline Oral Solution

Sponsor: Fondazione G.B. Bietti, IRCCS

Conditions Non-arteritic Ischemic Optic Neuropathy

Interventions Citicoline

Updated 5 times since 2018 Last updated: Feb 14, 2023 Started: Feb 20, 2017 Primary completion: Jul 25, 2017 Completion: Apr 25, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Non-arteritic Ischemic Optic Neuropathy and is currently completed. Fondazione G.B. Bietti, IRCCS leads this study, which shows 5 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2023 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Dec 2023 [monthly]

Completed NA
Dec 2018 — Jan 2021 [monthly]

Completed NA

First recorded

Feb 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione G.B. Bietti, IRCCS

Data source: Fondazione G.B. Bietti, IRCCS

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Roma, Italy